Johnson & Johnson operates in the healthcare sector, focusing on Innovative Medicine and MedTech segments after spinning off its Consumer Health business in 2023. The Innovative Medicine segment, contributing approximately 55% of revenue, includes prescription products for complex diseases such as rheumatoid arthritis and various cancers. The MedTech segment, accounting for about 45% of revenue, provides medical devices and technology solutions for healthcare professionals and hospitals. Factors supporting the company's endurance include its long history, strong brand recognition, and ongoing investment in research and development. However, challenges may arise from regulatory pressures, competition in the pharmaceutical and medical device markets, and potential litigation risks.
—
Johnson & Johnson operates in the healthcare sector, focusing on Innovative Medicine and MedTech segments after spinning off its Consumer Health business in 2023. The Innovative Medicine segment, contributing approximately 55% of revenue, includes prescription products for complex diseases such as rheumatoid arthritis and various cancers. The MedTech segment, accounting for about 45% of revenue, provides medical devices and technology solutions for healthcare professionals and hospitals. Factors supporting the company's endurance include its long history, strong brand recognition, and ongoing investment in research and development. However, challenges may arise from regulatory pressures, competition in the pharmaceutical and medical device markets, and potential litigation risks.
—
Daily adjusted close
Johnson & Johnson operates in the healthcare sector, focusing on Innovative Medicine and MedTech segments after spinning off its Consumer Health business in 2023. The Innovative Medicine segment, contributing approximately 55% of revenue, includes prescription products for complex diseases such as rheumatoid arthritis and various cancers. The MedTech segment, accounting for about 45% of revenue, provides medical devices and technology solutions for healthcare professionals and hospitals. Factors supporting the company's endurance include its long history, strong brand recognition, and ongoing investment in research and development. However, challenges may arise from regulatory pressures, competition in the pharmaceutical and medical device markets, and potential litigation risks.